Merrill A. McPeak, Director at IOVANCE BIOTHERAPEUTICS, INC. (IOVA), bought 20,000 shares at $6.84 ($136K) on 2022-05-31, disclosed to the SEC on 2022-06-02.
Open-market purchase of $136k IOVA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.80 | 10,000 | $68K | 49.9% |
| 2 | $6.84 | 10,000 | $68K | 50.1% |
| Total | $6.82 avg | 20,000 | $136K | 100% |
| Filing → |
| IOVA | BUY | 2022-12-22 | $62K | — | Filing → |
| IOVA | BUY | 2022-11-30 | $126K | — | Filing → |
| IOVA | BUY | 2022-11-28 | $62K | — | Filing → |